Clinical Trials Logo

Clinical Trial Summary

PrEvention of posttraumatic contractuRes with Ketotifen 2 (PERK 2) is a Phase III randomized, controlled, double blinded multicenter trial with 3 parallel groups (Ketotifen 2 mg or 5 mg or lactose placebo twice daily orally for 6 weeks) and a primary endpoint of elbow extension-flexion range of motion (ROM) arc at 12 weeks post-randomization.


Clinical Trial Description

PrEvention of posttraumatic contractuRes with Ketotifen 2 (PERK2) is a Phase III randomized, controlled, double blinded multicenter trial with 3 parallel groups (Ketotifen 2 mg or 5 mg or lactose placebo twice daily orally for 6 weeks) and a primary endpoint of elbow extension-flexion range of motion (ROM) arc at 12 weeks post-randomization. The Research Hypothesis is that Ketotifen is superior to a lactose placebo in reducing joint contracture severity in adult participants with isolated elbow fractures or dislocations. The Primary Objective is to determine if Ketotifen given within 10 days of injury can reduce post-traumatic elbow joint contractures when compared to placebo. The Secondary Objectives are: 1) to ascertain the optimal dose of Ketotifen and 2) to compare adverse events in Ketotifen and placebo groups. Inclusion criteria: age ≥ 18 years old and skeletally mature; distal humerus (AO/OTA type 13) and/or proximal ulna and/or proximal radius fractures (AO/OTA type 2U1/2R1) and/or elbow dislocations (open fractures with or without nerve injury may be included); injury ≤ 10 days; ability to give informed consent; able to comply with protocol and follow up; operative treatment of the elbow fracture or dislocation; participant has negative urine or blood serum pregnancy test. Exclusion criteria: Pre-existing elbow contracture; elbow arthritis (osteoarthritis, inflammatory arthritis, or nonspecific monoarticular arthritis); inability to mobilize elbow within 21 days of injury; bilateral elbow injury; oral hypoglycemic medications; history of epilepsy; lactose intolerance; language or cognitive difficulties preventing completion of questionnaires; pregnancy; breast feeding; male or female unwilling to use 2 methods of contraception; total elbow replacement planned for treatment of fracture or dislocation; prior elbow injury or operation; concomitant musculoskeletal or visceral injuries preventing post-operative elbow therapy; severe renal and hepatic impairment. Outcome Measures: Range of motion; Disability Arm, Shoulder, Hand; Oxford Elbow Score; Pain Catastrophizing Scale; standardized case report form; radiographic evaluation for fracture healing/non-union; and number of participants requiring reoperation for all elbow related causes, and post-traumatic joint contractures, 2 - 52 weeks post-randomization. Safety Endpoints: The main safety endpoint for this study is the frequency of adverse events and serious adverse events, and radiographic assessment for non-union and heterotopic ossification (HO), 2 - 52 weeks post-randomization. Ketotifen is the first and only agent demonstrating a significant decrease in contracture severity in preclinical trials that also has a wide safety profile. Ketotifen has been used in the treatment of chronic asthma for over 40 years in humans. Ketotifen is a medication that has anti-anaphylactic properties, due to the prevention of the synthesis and/or release of growth factors and mediators, as well as antihistamine affects due to H1 receptor antagonism. Post market surveillance has confirmed the safety of Ketotifen. A Phase II RCT comparing a single dose of Ketotifen (5 mg) to placebo in elbow fractures or dislocations in Calgary (ClinicalTrials.gov Identifier NCT01902017), demonstrated safety of Ketotifen and coupled with preclinical animal studies informed the need to increase the sample size, examine multiple doses, and narrow the study population to more severe injuries requiring an operation in the Phase III RCT. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03582176
Study type Interventional
Source University of Calgary
Contact
Status Active, not recruiting
Phase Phase 3
Start date April 26, 2019
Completion date December 29, 2025

See also
  Status Clinical Trial Phase
Terminated NCT00580866 - Progressive Splinting Status Post Elbow Fractures and Dislocations N/A
Terminated NCT00991887 - Radiation Therapy for Heterotopic Ossification Prophylaxis Acutely After Elbow Trauma N/A
Completed NCT01944085 - Percutaneous Pin Removal in Children - is Analgesia Necessary? N/A
Completed NCT03969277 - Graded Motor Imagery in Elbow Limitation N/A
Recruiting NCT05602077 - Accuracy of Sonography in Elbow Trauma N/A
Completed NCT02878941 - Synovial Fluid Analysis of Intraarticular Elbow Fracture N/A
Not yet recruiting NCT05780398 - Long Term Follow up in Pediatric Supracondylar Humeral Fracture
Completed NCT05391139 - Acute Effects of Dual Task on Physical Function in Patients With Elbow Joint Fracture
Completed NCT05380219 - Effects of Dual Task on Physical Function in Patients With Elbow Joint Fracture N/A
Completed NCT04872205 - The Turkish Version of the Shanghai Elbow Dysfunction Score
Completed NCT01328782 - The Post-Operative Pain Management of Pediatric Supracondylar Elbow Fractures N/A
Terminated NCT04738318 - Steroid Administration for Articular Fractures of the Elbow (SAFE Trial) Phase 4
Not yet recruiting NCT05437133 - Reliability and Validity of Self-reported Adherence to Elbow Orthosis Wearing Time
Withdrawn NCT05075382 - Fracture and Neurological Injury
Completed NCT03302533 - Can Secondary Total Elbow Arthroplasty After Failed Internal Fixation or Non-operative Treatment of Distal Humeral Fractures Achieve Equal Results as Primary Arthroplasty? N/A
Completed NCT05870345 - Pocket Sized Ultrasound (PsUS) and Pediatric Elbow Fractures N/A
Completed NCT05258162 - Comparison of Mobilization and MET Post-Traumatic Elbow Stiffness N/A
Not yet recruiting NCT04648488 - Early Mobilisation After Surgery in Patients With Elbow Fracture-dislocation N/A
Completed NCT03161782 - The Efficacy of Different Types of Stretching on Range of Motion, Pain and Function in Elbow Limitation N/A
Completed NCT03379935 - Radial Head Arthroplasty A Clinical and Radiological Comparison of Monopolar and Bipolar Radial Head Arthroplasty N/A